Literature DB >> 33554308

Emerging Multi-Drug Eutectics: Opportunities and Challenges.

Jamshed Haneef1, Shakir Ali2, Renu Chadha3.   

Abstract

Complexity and heterogeneous nature of most diseases have posed greater challenges in the modern healthcare system. Fixed-dose combination can offer an ideal way to improve patient compliance and higher therapeutic efficacy. However, biopharmaceutical issues associated with the drug combinations remain unaddressed. Multidrug eutectics (MDE) have demonstrated significant promise in improving the biopharmaceutical attributes with synergistic therapeutic action. Eutectic mixtures are the multicomponent solid forms that possess lesser melting point than the individual components at a fixed composition. Non-covalent linking of drug combinations as MDE is an innovative strategy with enhanced solubility, dissolution, and mechanical and potential therapeutic efficacy. This review provides a comprehensive overview of the design of MDE, rational selection of drugs, characterization tools, and their therapeutic potential. Besides, the futuristic perspective where MDE could make a significant impact on combination therapy is briefly outlined. Graphical Abstract.

Entities:  

Keywords:  crystal engineering; eutectic mixtures; fixed-dose combination; non-covalent derivative; thermal analysis

Mesh:

Substances:

Year:  2021        PMID: 33554308     DOI: 10.1208/s12249-021-01939-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  24 in total

1.  Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure.

Authors:  Devalina Law; Weili Wang; Eric A Schmitt; Yihong Qiu; Steven L Krill; James J Fort
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

Review 2.  Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms.

Authors:  Divyakant Desai; Jennifer Wang; Hong Wen; Xuhong Li; Peter Timmins
Journal:  Pharm Dev Technol       Date:  2012-02-16       Impact factor: 3.133

Review 3.  Multidrug co-crystals: towards the development of effective therapeutic hybrids.

Authors:  Rajesh Thipparaboina; Dinesh Kumar; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Discov Today       Date:  2016-02-08       Impact factor: 7.851

Review 4.  Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs.

Authors:  Giovana Carolina Bazzo; Bianca Ramos Pezzini; Hellen Karine Stulzer
Journal:  Int J Pharm       Date:  2020-08-09       Impact factor: 5.875

Review 5.  Cyclodextrin-based pharmaceutics: past, present and future.

Authors:  Mark E Davis; Marcus E Brewster
Journal:  Nat Rev Drug Discov       Date:  2004-12       Impact factor: 84.694

6.  Resolving issues of content uniformity and low permeability using eutectic blend of camphor and menthol.

Authors:  M C Gohel; S A Nagori
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

Review 7.  Eutectic lidocaine/prilocaine cream. A review of the topical anaesthetic/analgesic efficacy of a eutectic mixture of local anaesthetics (EMLA).

Authors:  M M Buckley; P Benfield
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

8.  Nanoparticles for combination drug therapy.

Authors:  Liang Ma; Manish Kohli; Andrew Smith
Journal:  ACS Nano       Date:  2013-11-26       Impact factor: 15.881

Review 9.  Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis.

Authors:  Paweł Kawalec; Przemysław Holko; Małgorzata Gawin; Andrzej Pilc
Journal:  Arch Med Sci       Date:  2018-08-13       Impact factor: 3.318

Review 10.  Non-Covalent Derivatives: Cocrystals and Eutectics.

Authors:  Emily Stoler; John C Warner
Journal:  Molecules       Date:  2015-08-14       Impact factor: 4.411

View more
  1 in total

1.  Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations.

Authors:  Agata Górniak; Adrianna Złocińska; Mateusz Trojan; Adrianna Pęcak; Bożena Karolewicz
Journal:  Pharmaceutics       Date:  2022-04-22       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.